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Anti-filarial (anti- B. malayi adult as well as anti- B. malayi microfilarial) IgG antibody levels were measured by enzyme
linked immunosorbent assay (ELISA) in asymptomatic microfilaria carriers, acute, chronic and tropical pulmonary
eosinophilia (TPE) patients, endemic and non-endemic controls. Controls from endemic areas had higher antibody titres
compared with controls from non-endemic areas. The antibody response in different groups of filariasis patients was not stage
specific. There were no association between clinical disease and antibody levels except in TPE. Though TPE patients had very
high antibody levels, a proportion of them had low levels suggesting heterogeneity in TPE population.
Most of the attention on filariasis immunity has been
focussed around the humoral antibody response1.
Almost every available assay has been employed to
measure antibody response in filariasis patients2,3.
Often, claims have been made about the specificity of
the assays and their use in diagnosis of filarial disease4.
Some correlations have been established between the
microfilaraemia and the antibody levels5. However,
there is a need for studies to correlate the antibody
response, qualitatively and quantitatively, with clinical
progression and manifestation of the disease. We have
used enzyme linked immunosorbent assay (ELISA) to
measure anti-filarial antibody against adult and micro-
filarial somatic antigens of Brugia malayi in patients
with acute and chronic manifestations as well as occult
form of the disease, tropical pulmonary eosinophilia
(TPE).
Materials and Methods
Nine asymptomatic microfilaria carriers, 18 early
filariasis patients, 15 chronic filariasis patients, 27 TPE
patients, 15 normal healthy controls living in the same
area (Madras) and 13 non-endemic controls from non-
endemic area (Delhi) were studied.
Early filariasis patients had histories of episodes of
acute lymphangitis and lymphadenitis, fever and pit-
ting edema of the limbs (of duration not more than a
year). The chronic filariasis patients had either
elephantiasis or chyluria as a major manifestation of
the disease. TPE patients presented with nocturnal
cough, wheeze, breathlessness and high circulating
eosinophil counts (> 2000/mm3).
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Brugia malayi adult worm (BmA) and microfilarial
(Bm/mf/S) antigens were saline extracts of the
sonicates of these worms. They were standardized for
protein content as measured by Lowry’s method6.
ELISA was carried out according to Narayanan
et al 7. In brief, plates coated with antigen (2 µg/ml) in
alkaline buffer were washed thrice and incubated with
doubling dilutions (1/40 to 1/5120) of the sera for 30
min. The plates were washed again and incubated with
1/1000 dilution of antihuman IgG–horse radish
peroxidase (HRP) conjugate (Cappel Labs., PA,
USA). The buffer used for washing and dilutions was
0.02 M PBS (pH 7.2) with 0.05% tween-20 as a de-
tergent. The plates were. washed after 30 min and
further incubated with freshly prepared substrate
orthophenylenediamine (0.002% w/v with 0.003%
H2O2. The reaction was read at 30 min after addition
of 8N H2SO4 to stop the reaction. The last dilution
showing colour development was taken as the serum
titre.
Results and Discussion
Anti-adult worm (BmA) and anti-microfilarial
(Bm/mf/S) antibodies were detected in all filariasis
patients, irrespective of the duration of the disease as
well as parasitological status. The antibodies were also
detected in endemic volunteers. The presence of anti-
bodies in endemic volunteers does cast a doubt on the
specificity of the antibody response. However, the
nonendemic controls who have minimal chance of
exposure to filarial parasites have very low antibody
levels; thus validating the assay by ruling out non-
specific binding of serum antibodies to the antigen.
Since the binding is not of non-specific nature, the
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endemic volunteers either have anti-filarial antibody
response of considerable magnitude or they have cross
reacting antibodies. Similar findings have been re-
ported using indirect fluorescence antibody test with
W. bancrofti excretory-secretory antigen8. Earlier,
Kaliraj et al. 9 also reported presence of antibodies in
endemic normal controls. Since the antibodies are
present in normal controls and almost absent in non-
endemic controls, the antibody levels in the com-
munity could be considered as a parameter of ende-
micity of infection. Antibodies are present in serum
always unlike microfilaria that are present only during
night time, hence, making the night blood examination
difficult. Hence, antibody measurement could be used
as an alternative to night blood examination in
epidemiological studies.
However, the relationship between antibody levels
and rate of infection in community and the quantum of
infection has not been studied as yet. Such studies
should be done to evaluate the use of anti-filarial
antibodies in seroepidemiology of filariasis.
Little difference was observed between antibody
levels as measured by the adult or microfilarial antigen
in any of the categories (Table 1). This may be
explained by postulating that the antibody response is
Table I – Anti-filarial Antibody Titres in Filarial Patients
and Volunteers
Clinical category
Mean IgG titres (range)
No. of
subjects Anti-BmA Anti-Bm/mf/S
Non-endemic normals 13
Endemic normals 15
Asymptomatic mf 9
carriers
Early filariasis 18
Chronic filariasis 15
Tropical pulmonary 27
eosinophilia
Table 2 – Anti-filarial Antibody Titres in Filariasis Patients
with or without Microfilaraemia
Microfila-
raemia status
Mf +ve
Mf –ve
P value
Mean IgG titres (range)
No. of
specimens Anti-BmA Anti-Bm/mf/S
22
18
directed largely to the antigens that are common to two
different stages of the parasite. It is difficult to explain
the role of antibody responsein filariasis immunity as
the response is neither directed to stage specific
antigens nor related to the manifestations of the
disease (either acute or chronic) except in case of TPE.
Another aspect of antibody response in filariasis is the
cross reactivity of filarial antigens with antigens of
other helminthic parasites. We have demonstrated the
cross reactivity of filarial antigens with ascaris antigens
using TPE sera.
In TPE individuals mean anti-filarial antibody titre
is almost 10 times of that in controls and filariasis
patients. This is in confirmity with findings of Neva
and Ottesen10. Though mean antibody level in TPE is
very high, a small proportion of TPE patients who
otherwise confirmed to the clinical picture of TPE, had
lower antibody titres. It is not known what this
heterogeneity means in terms of aetiology and pa-
thology of the disease.
Lastly, when the patients were classified on the basis
of their parasitological status, those with circulating
microfilariae had lower antibody titres compared with
those without microfilaraemia (Table 2). Our findings
are contrary to those of Grove and Davis5 who could
detect anti-microfilarial antibodies only in chronic
filariasis patients (most of whom had become microfi-
laria negative). This could easily be explained as they
had used whole microfilariae as the antigen and not
sonicate of microfilariae as used by us. Hedge and
Ridley 11 used the sonicate of B. pahangi and could
detect antibodies in almost 100% of the patients
studied. The lower levels of antibody titres in microfi-
laria positive patients may be due to absorption of
antibodies onto the surface of microfilaria or may be
due to the suppression of antibody production.
Though there was no association between the course
of the disease (acute or chronic) in lymphatic form of
flariasis, a high IgG response (in TPE sera) and
relatively low antibody levels in microfilarimics were
observed. The relevance of increased IgG levels in TPE
needs further attention. Also, the significance and
implications of low IgG antibody levels in a small
proportion of TPE patients needs to be understood.
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